<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Chronic Myeloid Leukaemia &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/chronic-myeloid-leukaemia/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 20 Jan 2026 19:11:08 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Chronic Myeloid Leukaemia &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Ponatinib Achieves Deep Response in CML After Imatinib</title>
		<link>https://bioengineer.org/ponatinib-achieves-deep-response-in-cml-after-imatinib/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 20 Jan 2026 19:10:39 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Chronic Myeloid Leukaemia]]></category>
		<category><![CDATA[CML'de derin moleküler yanıt]]></category>
		<category><![CDATA[Consolidation Therapy]]></category>
		<category><![CDATA[Deep Molecular Response]]></category>
		<category><![CDATA[Imatinib]]></category>
		<category><![CDATA[İmatinib sonrası Ponatinib]]></category>
		<category><![CDATA[İşte içerik için uygun 5 etiket (virgülle ayrılmış): **Ponatinib konsolidasyon tedavisi]]></category>
		<category><![CDATA[Kronik miyeloid lösemi tedavisi]]></category>
		<category><![CDATA[Ponatinib]]></category>
		<category><![CDATA[Tirozin kinaz inhibitörleri** **Açıklama:** 1. **Ponatinib kons]]></category>
		<guid isPermaLink="false">https://bioengineer.org/ponatinib-achieves-deep-response-in-cml-after-imatinib/</guid>

					<description><![CDATA[In the constantly evolving landscape of chronic myeloid leukaemia (CML) treatment, a groundbreaking study by Pérez-Lamas et al. has surfaced, providing compelling evidence regarding the efficacy of consolidation therapy with Ponatinib after achieving deep molecular response with Imatinib. As CML remains a prevalent hematological malignancy, understanding the nuances of treatment strategies is imperative for optimizing [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">319107</post-id>	</item>
		<item>
		<title>Explosive Rise in Blood Cancer Linked to Single Genetic Mutation</title>
		<link>https://bioengineer.org/explosive-rise-in-blood-cancer-linked-to-single-genetic-mutation/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 09 Apr 2025 17:58:45 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[BCR-ABL1 Fusion Gene]]></category>
		<category><![CDATA[cancer progression]]></category>
		<category><![CDATA[Chronic Myeloid Leukaemia]]></category>
		<category><![CDATA[genetic mutation]]></category>
		<category><![CDATA[tyrosine kinase inhibitors]]></category>
		<guid isPermaLink="false">https://bioengineer.org/explosive-rise-in-blood-cancer-linked-to-single-genetic-mutation/</guid>

					<description><![CDATA[A groundbreaking study has illuminated the timeline and growth patterns of chronic myeloid leukaemia (CML), a type of cancer that primarily impacts the blood and bone marrow. This research, conducted by scientists from the Wellcome Sanger Institute, reveals previously undocumented rates of rapid cell proliferation that occur years prior to a formal cancer diagnosis. It [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">240452</post-id>	</item>
	</channel>
</rss>
